Molecular Pharmacology | |
Stock Exchange | Other OTC |
EPS |
$0 |
Market Cap |
$206.38 K |
Shares Outstanding |
111.55 M |
Public Float |
23.55 M |
Address |
Drug Discovery Research Centre Perth Western Australia (WA) 6007 Australia |
Employees | - |
Website | - |
Updated | 07/08/2019 |
Molecular Pharmacology (USA) Ltd. engages in the development of pharmaceutical products. The firm operates through the Australia and the Unites States geographical segments. It also commercializes an analgesic and anti-inflammatory drug under the Tripeptofen brand. |